MedTrace Logo

National Bacterial Meningitis Study in Children and Newborns

NCT04664569 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2026-04-28

No results posted yet for this study

Summary

Bacterial meningitis is a major cause of morbidity and mortality in childhood. Antibiotic treatment recommendations are based on epidemiological and susceptibility data. The epidemiology of bacterialméningitis has changed in recent years, mainly owing to widespread use of different conjugate vaccines. The aim of this prospective national survey is to describe epidemiology of bacteria implicated in bacterial meningitis in children.

Conditions

  • Meningitis
  • Children, Only
  • Pneumococcal Conjugate Vaccine
  • Meningococcal Vaccines
  • H. Influenzae Vaccine
  • Neonatal Infection
  • Antibiotic Treatment
  • Case Fatality Rate

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Association Clinique Thérapeutique Infantile du val de Marne

    lead OTHER

Principal Investigators

  • Corinne Levy, MD · Association Clinique Thérapeutique Infantile du val de Marne

  • Robert Cohen · Association Clinique Thérapeutique Infantile du val de Marne

Eligibility

Min Age
1 Day
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-01-01
Primary Completion
2030-01-01
Completion
2030-01-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04664569 on ClinicalTrials.gov